Stay updated on ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Results posting information was added (Results First Posted 2026-02-17; Results First Submitted 2024-03-25), and the study now includes Exploratory Arm 1 and 2 as well as Arm B (RP2D) with related dosing details.
    Difference
    6%
    Check dated 2026-02-20T09:44:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T03:43:02.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page shows a minor site revision from v3.4.0 to v3.4.1; no changes to study content or navigation are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T12:19:26.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page shows a new revision tag 'Revision: v3.3.4' replacing the previous 'Revision: v3.3.3', a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:06:24.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Locations information was updated: a new Locations section lists Florida, Minnesota, Ohio, and South Carolina, with the previous state entries removed; the HHS Vulnerability Disclosure link was also removed.
    Difference
    0.5%
    Check dated 2025-12-24T12:21:13.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    PubMed publications description was updated to indicate automatic filling from PubMed, and a revision note shows version v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:15:36.000Z thumbnail image

Stay in the know with updates to ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.